Question 1

What is the catalog number for JNJ-7706621?

Accepted Answer

The catalog number for JNJ-7706621 is B1941-5.

Question 2

Is JNJ-7706621 in stock?

Accepted Answer

JNJ-7706621 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is JNJ-7706621 used for?

Accepted Answer

JNJ-7706621 is a potent inhibitor of cyclin-dependent kinases (CDK) and Aurora kinases with IC₅₀ values of 9 nM, 4 nM, 11 nM and 15 nM for CDK1, 2 and Aurora A, B, respectively. In vitro assays shows that JNJ-7706621 inhibits glioblastoma cellular viability, proliferation, and migration via inducing

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

JNJ-7706621

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

Anti-CD47 Antibody-APC labled

Anti-CD47 Antibody-APC labled

Anti-CD47 Antibody-APC labled

Recombinant Aspergillus oryzae Eukaryotic translation initiation factor 3 subunit I (tif34)

Recombinant Aspergillus oryzae Eukaryotic translation initiation factor 3 subunit I (tif34)

Recombinant Aspergillus oryzae Eukaryotic translation initiation factor 3 subunit I (tif34)